Add to ORKGThirty patients suffering from WHO I-II class slight-moderate essential arterial hypertension were treated with a beta-blocker (Penbutolol) alone and once a day to assess its antihypertensive effectiveness and its affect on heart frequency, lipid metabolism and kidney function. The drug proved highly effective in reducing P.A.S. and P.A.D. values and no negative influence was documented on lipid metabolism, kidney function or heart frequency
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, p...
The research over 1023 patients examined in a metallurgical firm for prevalence of essential hyperte...
The use of beta blockers as first-line therapy for hyperten-sion has been widely conceptual for a lo...
Thirty patients suffering from WHO I-II class slight-moderate essential arterial hypertension were t...
A pilot single-blind placebo controlled crossover within-patient study was undertaken in essential h...
For more than 30 years, beta-blockers have widely been used in the treatment of patients with myocar...
We investigated the effect of an orally administered, long-acting, beta-adrenergic blocking agent, p...
Betablockers are first-line treatment of arterial hyperten-sion along with diuretics according to th...
(beta)-blockers are standard therapy in patients with cardiovascular disease, and have become a corn...
<p>Data of the largest meta-analyzes of beta-blockers use in arterial hypertension is presented. The...
This randomized double-blind controlled study analyzed the hemodynamic effects of penbutolol, a new ...
The antihypertensive efficacy and the acceptability of nifedipine (NI, Adalat) and the usefulness of...
Beta-blockers showed better results in lowering elevated blood pressure in the younger age group of ...
AbstractObjectivesTo quantify the potential harm of beta blockers in patients with peripheral arteri...
Beta-blockers have solid documentation in preventing cardiovascular complications in the treatment o...
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, p...
The research over 1023 patients examined in a metallurgical firm for prevalence of essential hyperte...
The use of beta blockers as first-line therapy for hyperten-sion has been widely conceptual for a lo...
Thirty patients suffering from WHO I-II class slight-moderate essential arterial hypertension were t...
A pilot single-blind placebo controlled crossover within-patient study was undertaken in essential h...
For more than 30 years, beta-blockers have widely been used in the treatment of patients with myocar...
We investigated the effect of an orally administered, long-acting, beta-adrenergic blocking agent, p...
Betablockers are first-line treatment of arterial hyperten-sion along with diuretics according to th...
(beta)-blockers are standard therapy in patients with cardiovascular disease, and have become a corn...
<p>Data of the largest meta-analyzes of beta-blockers use in arterial hypertension is presented. The...
This randomized double-blind controlled study analyzed the hemodynamic effects of penbutolol, a new ...
The antihypertensive efficacy and the acceptability of nifedipine (NI, Adalat) and the usefulness of...
Beta-blockers showed better results in lowering elevated blood pressure in the younger age group of ...
AbstractObjectivesTo quantify the potential harm of beta blockers in patients with peripheral arteri...
Beta-blockers have solid documentation in preventing cardiovascular complications in the treatment o...
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, p...
The research over 1023 patients examined in a metallurgical firm for prevalence of essential hyperte...
The use of beta blockers as first-line therapy for hyperten-sion has been widely conceptual for a lo...